Selected research
Industry Growth & Trends
Global Clinical Pathology AI Software Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Clinical Pathology AI Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Clinical Pathology AI Software is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Clinical Pathology AI Software is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Clinical Pathology AI Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Clinical Pathology AI Software market include PathAI, Proscia, Aiforia, Deep Bio, Hologic, Dipath, iDeepwise, LBP and F.Q pathtech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Clinical Pathology AI Software market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Clinical Pathology AI Software market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Clinical Pathology AI Software market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Clinical Pathology AI Software.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Clinical Pathology AI Software market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Clinical Pathology AI Software Market by Company
PathAI
Proscia
Aiforia
Deep Bio
Hologic
Dipath
iDeepwise
LBP
F.Q pathtech
CellaVision
AIRA Matrix
Syntropy
Indica Labs
DoMore Diagnostics
Mindpeak
Evidium
Clinical Pathology AI Software Segment by Type
Cloud-Based
On-Premise
Clinical Pathology AI Software Segment by Application
Hospital
Diagnostic Centers
Laboratories & Research Institutes
Clinical Pathology AI Software Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Clinical Pathology AI Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Clinical Pathology AI Software and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Clinical Pathology AI Software.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Clinical Pathology AI Software companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Cloud-Based
- On-Premise
Applications
- Hospital
- Diagnostic Centers
- Laboratories & Research Institutes
Companies covered
- PathAI
- Proscia
- Aiforia
- Deep Bio
- Hologic
- Dipath
- iDeepwise
- LBP
- F.Q pathtech
- CellaVision
- AIRA Matrix
- Syntropy
- Indica Labs
- DoMore Diagnostics
- Mindpeak
- Evidium
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Clinical Pathology AI Software Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Clinical Pathology AI Software Market Size by Region (2021-2032)
- 1.4.1 Global Clinical Pathology AI Software Market Size by Region (2021-2026)
- 1.4.2 Global Clinical Pathology AI Software Market Size by Region (2027-2032)
- 1.5 Key Regions Clinical Pathology AI Software Market Size (2021-2032)
- 1.5.1 North America Clinical Pathology AI Software Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Clinical Pathology AI Software Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Clinical Pathology AI Software Market Size Growth Rate (2021-2032)
- 1.5.4 South America Clinical Pathology AI Software Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Clinical Pathology AI Software Market Size Growth Rate (2021-2032)
2 Clinical Pathology AI Software Market by Type
- 2.1 Type Introduction
- 2.1.1 Cloud-Based
- 2.1.2 On-Premise
- 2.2 Global Clinical Pathology AI Software Market Size by Type
- 2.2.1 Global Clinical Pathology AI Software Market Size Overview by Type (2021-2032)
- 2.2.2 Global Clinical Pathology AI Software Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Clinical Pathology AI Software Market Size Forecasted by Type (2027-2032)
- 2.3 Global Clinical Pathology AI Software Market Size by Regions
- 2.3.1 North America Clinical Pathology AI Software Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Clinical Pathology AI Software Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Clinical Pathology AI Software Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Clinical Pathology AI Software Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Clinical Pathology AI Software Market Size Breakdown by Type (2021-2026)
3 Clinical Pathology AI Software Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Diagnostic Centers
- 3.1.3 Laboratories & Research Institutes
- 3.2 Global Clinical Pathology AI Software Market Size by Application
- 3.2.1 Global Clinical Pathology AI Software Market Size Overview by Application (2021-2032)
- 3.2.2 Global Clinical Pathology AI Software Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Clinical Pathology AI Software Market Size Forecasted by Application (2027-2032)
- 3.3 Global Clinical Pathology AI Software Market Size by Regions
- 3.3.1 North America Clinical Pathology AI Software Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Clinical Pathology AI Software Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Clinical Pathology AI Software Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Clinical Pathology AI Software Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Clinical Pathology AI Software Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Clinical Pathology AI Software Industry Trends
- 4.2 Clinical Pathology AI Software Industry Drivers
- 4.3 Clinical Pathology AI Software Industry Opportunities and Challenges
- 4.4 Clinical Pathology AI Software Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Clinical Pathology AI Software Revenue (2021-2026)
- 5.2 Global Clinical Pathology AI Software Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Clinical Pathology AI Software Key Company Headquarters & Area Served
- 5.4 Global Clinical Pathology AI Software Company, Product Type & Application
- 5.5 Global Clinical Pathology AI Software Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Clinical Pathology AI Software Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Clinical Pathology AI Software Players Market Share by Revenue in 2025
- 5.6.3 2025 Clinical Pathology AI Software Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 PathAI
- 6.1.1 PathAI Company Information
- 6.1.2 PathAI Business Overview
- 6.1.3 PathAI Clinical Pathology AI Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 PathAI Clinical Pathology AI Software Product Portfolio
- 6.1.5 PathAI Recent Developments
- 6.2 Proscia
- 6.2.1 Proscia Company Information
- 6.2.2 Proscia Business Overview
- 6.2.3 Proscia Clinical Pathology AI Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Proscia Clinical Pathology AI Software Product Portfolio
- 6.2.5 Proscia Recent Developments
- 6.3 Aiforia
- 6.3.1 Aiforia Company Information
- 6.3.2 Aiforia Business Overview
- 6.3.3 Aiforia Clinical Pathology AI Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Aiforia Clinical Pathology AI Software Product Portfolio
- 6.3.5 Aiforia Recent Developments
- 6.4 Deep Bio
- 6.4.1 Deep Bio Company Information
- 6.4.2 Deep Bio Business Overview
- 6.4.3 Deep Bio Clinical Pathology AI Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Deep Bio Clinical Pathology AI Software Product Portfolio
- 6.4.5 Deep Bio Recent Developments
- 6.5 Hologic
- 6.5.1 Hologic Company Information
- 6.5.2 Hologic Business Overview
- 6.5.3 Hologic Clinical Pathology AI Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Hologic Clinical Pathology AI Software Product Portfolio
- 6.5.5 Hologic Recent Developments
- 6.6 Dipath
- 6.6.1 Dipath Company Information
- 6.6.2 Dipath Business Overview
- 6.6.3 Dipath Clinical Pathology AI Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Dipath Clinical Pathology AI Software Product Portfolio
- 6.6.5 Dipath Recent Developments
- 6.7 iDeepwise
- 6.7.1 iDeepwise Company Information
- 6.7.2 iDeepwise Business Overview
- 6.7.3 iDeepwise Clinical Pathology AI Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 iDeepwise Clinical Pathology AI Software Product Portfolio
- 6.7.5 iDeepwise Recent Developments
- 6.8 LBP
- 6.8.1 LBP Company Information
- 6.8.2 LBP Business Overview
- 6.8.3 LBP Clinical Pathology AI Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 LBP Clinical Pathology AI Software Product Portfolio
- 6.8.5 LBP Recent Developments
- 6.9 F.Q pathtech
- 6.9.1 F.Q pathtech Company Information
- 6.9.2 F.Q pathtech Business Overview
- 6.9.3 F.Q pathtech Clinical Pathology AI Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 F.Q pathtech Clinical Pathology AI Software Product Portfolio
- 6.9.5 F.Q pathtech Recent Developments
- 6.10 CellaVision
- 6.10.1 CellaVision Company Information
- 6.10.2 CellaVision Business Overview
- 6.10.3 CellaVision Clinical Pathology AI Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.10.4 CellaVision Clinical Pathology AI Software Product Portfolio
- 6.10.5 CellaVision Recent Developments
- 6.11 AIRA Matrix
- 6.11.1 AIRA Matrix Company Information
- 6.11.2 AIRA Matrix Business Overview
- 6.11.3 AIRA Matrix Clinical Pathology AI Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.11.4 AIRA Matrix Clinical Pathology AI Software Product Portfolio
- 6.11.5 AIRA Matrix Recent Developments
- 6.12 Syntropy
- 6.12.1 Syntropy Company Information
- 6.12.2 Syntropy Business Overview
- 6.12.3 Syntropy Clinical Pathology AI Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.12.4 Syntropy Clinical Pathology AI Software Product Portfolio
- 6.12.5 Syntropy Recent Developments
- 6.13 Indica Labs
- 6.13.1 Indica Labs Company Information
- 6.13.2 Indica Labs Business Overview
- 6.13.3 Indica Labs Clinical Pathology AI Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.13.4 Indica Labs Clinical Pathology AI Software Product Portfolio
- 6.13.5 Indica Labs Recent Developments
- 6.14 DoMore Diagnostics
- 6.14.1 DoMore Diagnostics Company Information
- 6.14.2 DoMore Diagnostics Business Overview
- 6.14.3 DoMore Diagnostics Clinical Pathology AI Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.14.4 DoMore Diagnostics Clinical Pathology AI Software Product Portfolio
- 6.14.5 DoMore Diagnostics Recent Developments
- 6.15 Mindpeak
- 6.15.1 Mindpeak Company Information
- 6.15.2 Mindpeak Business Overview
- 6.15.3 Mindpeak Clinical Pathology AI Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.15.4 Mindpeak Clinical Pathology AI Software Product Portfolio
- 6.15.5 Mindpeak Recent Developments
- 6.16 Evidium
- 6.16.1 Evidium Company Information
- 6.16.2 Evidium Business Overview
- 6.16.3 Evidium Clinical Pathology AI Software Revenue, Global Share and Gross Margin (2021-2026)
- 6.16.4 Evidium Clinical Pathology AI Software Product Portfolio
- 6.16.5 Evidium Recent Developments
7 North America
- 7.1 North America Clinical Pathology AI Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Clinical Pathology AI Software Market Size by Country (2021-2026)
- 7.3 North America Clinical Pathology AI Software Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Clinical Pathology AI Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Clinical Pathology AI Software Market Size by Country (2021-2026)
- 8.3 Europe Clinical Pathology AI Software Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Clinical Pathology AI Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Clinical Pathology AI Software Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Clinical Pathology AI Software Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Clinical Pathology AI Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Clinical Pathology AI Software Market Size by Country (2021-2026)
- 10.3 South America Clinical Pathology AI Software Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Clinical Pathology AI Software Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Clinical Pathology AI Software Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Clinical Pathology AI Software Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst